SG PE's close links with Hanmi on focus The PE firm has taken part in Hanmi's new businesses over the past few years
이 기사는 2020년 05월 27일 08:00 더벨 유료페이지에 표출된 기사입니다.SG Private Equity (SG PE) is playing a significant role as a financial investor of South Korea’s Hanmi Pharmaceutical Group.
SG PE's close relationship with Hanmi started in 2014 when the PE firm invested in Ofmom Company. Ofmom Company, 100 percent owned by Hanmi owner’s three children, was established to tap into new overseas markets. SG PE acquired Ofmom Company’s redeemable convertible preference shares (RCPS) worth 25 billion won and convertible bonds worth 25 billion won in 2014. The proceeds were used to build Ofmom Company’s new powdered formula factory in China.
Three years later, the PE firm exited its investment in convertible bonds, with Ofmom Company exercising its call options. In July 2018, SG PE sold RCPS to Ofmom Company’s affiliated company to fully exit its investments. The PE firm’s investment in Ofmom Company recorded an internal rate of return (IRR) of 11.8 percent.
Ofmom Company started to seek a new business opportunity which can create synergies with its settled powdered formula business. At that time, SG PE and Plutus Equity Partners’ acquisition of local luxury postpartum care center DeRAMA attracted CEO of Hanmi Science Lim Chong-yoon’s attention. SG PE and Plutus took over DeRAMA through a 22.5 billion won project fund, in which Lim participated as a strategic investor. Lim’s aim was to weigh the possibility of expanding its business into China by helping the postpartum care center enter the Chinese market.
DeRAMA started its business in 2016 by leasing an entire floor of Marriott Hotel in Beijing and is currently preparing to enter the Thai market. Ofmom Company has recently taken over DeRAMA from SG PE and Plutus to create strong synergies between its powdered formula business and the postpartum care business.
SG PE is likely to keep its close relationship with Hanmi, considering it has repeatedly participated in the group’s new business as a financial investor. The PE firm is currently sitting on a large pile of cash, with the firm raising 500 billion won for its third blind-pool fund at the beginning of this year.
(Reporting by Se-hun Jo)
최신뉴스 in 전체기사
- VIG Partners to recapitalize Bonchon
- Stonebridge Ventures begins to exit Jeju Beer
- Doosan Group mulls whether to sell controlling stake in Doosan E&C
- Shinsegae denies agreement to buy eBay Korea
- TaylorMade deal likely to boost The Nature Holdings’ growth prospects
- Kakao holds treasury shares worth $315 mil
- Kwangju Bank to exit from China
- Centroid uses Acushnet deal as reference when picking its partner
- Eastar Jet to select final preferred bidder next week
- Stonebridge Capital in advanced talks to buy Health Balance
Translated by Kim So-in 의 다른 기사 보기
더벨 서비스 문의
02-724-4102유료 서비스 안내